FDA advisers unanimously backed Moderna’s mRNA flu vaccine mFlusiva on June 18. Here’s what the 9-0 vote means for fall 2026 vaccination and who it would cover.
FDA Panel Backs Moderna’s First mRNA Flu Shot — What It Could Mean for Your Fall Vaccine
by | Jun 25, 2026 | Uncategorized | 0 comments
Recent Comments